AAAAAA
Results: 1-25/69
Authors:
ROSNER AJ
GRIMA DT
TORRANCE GW
BRADLEY C
ADACHI JD
SEBALDT RJ
WILLISON DJ
Citation: Aj. Rosner et al., COST-EFFECTIVENESS OF MULTI-THERAPY TREATMENT STRATEGIES IN THE PREVENTION OF VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS, PharmacoEconomics, 14(5), 1998, pp. 559-573
Authors:
ADACHI JD
Citation: Jd. Adachi, CYCLICAL ETIDRONATE THERAPY IN THE PREVENTION AND TREATMENT OF CORTICOSTEROID-INDUCED OSTEOPOROSIS, Reviews in contemporary pharmacotherapy, 9(4), 1998, pp. 267-275
Authors:
BENSEN WG
BENSEN W
ADACHI JD
Citation: Wg. Bensen et al., THE PYRAMIDS OF RHEUMATOID-ARTHRITIS - REPLY, Journal of rheumatology, 25(4), 1998, pp. 819-819
Authors:
BENSEN W
BENSON W
ADACHI JD
Citation: W. Bensen et al., BACK TO THE FUTURE - THE PYRAMIDS OF RHEUMATOID-ARTHRITIS - REPLY, Journal of rheumatology, 25(3), 1998, pp. 602-602
Authors:
ADACHI JD
ARLEN D
WEBBER CE
CHETTLE DR
BEAUMONT LF
GORDON CL
Citation: Jd. Adachi et al., IS THERE ANY ASSOCIATION BETWEEN THE PRESENCE OF BONE-DISEASE AND CUMULATIVE EXPOSURE TO LEAD, Calcified tissue international, 63(5), 1998, pp. 429-432
Authors:
ADACHI JD
Citation: Jd. Adachi, ALENDRONATE FOR OSTEOPOROSIS - SAFE AND EFFICACIOUS NONHORMONAL THERAPY, Canadian family physician, 44, 1998, pp. 327-332
Authors:
ADACHI JD
Citation: Jd. Adachi, RESEARCH DATA ON ALENDRONATE - BIASED OPINIONS - RESPONSE, Canadian family physician, 44, 1998, pp. 974
Authors:
SEBALDT RJ
ADACHI JD
GORDON M
PETRIE A
GOLDSMITH CH
Citation: Rj. Sebaldt et al., ADDITION OF BISPHOSPHONATE THERAPY WITH ETIDRONATE OR ALENDRONATE TO STABLE ESTROGEN REPLACEMENT THERAPY IN POSTMENOPAUSAL WOMEN INCREASES LUMBAR SPINE AND FEMORAL TROCHANTER BONE-MINERAL DENSITY, Arthritis and rheumatism, 41(9), 1998, pp. 68-68
Authors:
SEBALDT RJ
ADACHI JD
BORATTO M
GORDON M
STEELE M
STEPHENSON GF
GOLDSMITH CH
Citation: Rj. Sebaldt et al., THE EFFECT OF ETIDRONATE ON LUMBAR SPINE BONE-MINERAL DENSITY IN MEN, Arthritis and rheumatism, 41(9), 1998, pp. 69-69
Authors:
HAQUENAUER D
MIRMIRAN S
WELCH V
ADACHI JD
TUGWELL P
WELLS G
SHEA B
Citation: D. Haquenauer et al., COCHRANE REVIEW ON FLUORIDE THERAPY TO PREVENT POSTMENOPAUSAL OSTEOPOROSIS, Arthritis and rheumatism, 41(9), 1998, pp. 607-607
Authors:
CRANNEY A
WELCH V
COYLE D
ADACHI JD
TUGWELL P
WELLS G
OTTEN N
SHEA S
BERTHELOT JM
WOLFSON M
FLANAGAN B
Citation: A. Cranney et al., COCHRANE REVIEW OF ALENDRONATE FOR PREVENTION AND TREATMENT OF POSTMENOPAUSAL OSTEOPOROSIS, Arthritis and rheumatism, 41(9), 1998, pp. 608-608
Authors:
ADACHI JD
BENSEN WG
ANASTASSIADES TP
BROWN JP
CHINES AA
OLSZYNSKI WP
HANLY JG
STEPHENSON GF
Citation: Jd. Adachi et al., ETIDRONATE IN THE PREVENTION OF CORTICOSTEROID-INDUCED OSTEOPOROSIS -ONE-YEAR OF FOLLOW-UP ON CALCIUM ONLY, Arthritis and rheumatism, 41(9), 1998, pp. 628-628
Authors:
SEBALDT RJ
ADACHI JD
BORATTO M
GORDON M
STEELE M
STEPHENSON GF
GOLDSMITH CH
Citation: Rj. Sebaldt et al., INTERMITTENT CYCLICAL THERAPY WITH ETIDRONATE PREVENTS CORTICOSTEROID-INDUCED BONE LOSS - 3 YEARS OF FOLLOW-UP, Arthritis and rheumatism, 41(9), 1998, pp. 1617-1617
Authors:
ADACHI JD
ROUX C
PACK S
CHINES AA
IOANNIDES G
STEPHENSON GF
HORLAIT S
Citation: Jd. Adachi et al., PREVENTION OF CORTICOSTEROID-INDUCED OSTEOPOROSIS WITH ETIDRONATE - POOLED RESULTS FROM 2 CLINICAL-TRIALS, Arthritis and rheumatism, 41(9), 1998, pp. 1624-1624
Authors:
COOK DJ
GUYATT GH
ADACHI JD
EPSTEIN RS
JUNIPER EF
AUSTIN PA
CLIFTON J
ROSEN J
KESENNICH CR
STOCK JL
OVERDORF J
MILLER PD
ERICKSON AL
MCLUNG M
LOVE B
GRIFFITH LE
Citation: Dj. Cook et al., MEASURING QUALITY-OF-LIFE IN WOMEN WITH OSTEOPOROSIS, Osteoporosis international, 7(5), 1997, pp. 478-487
Authors:
ADACHI JD
CHINES AA
STEPHENSON GF
PACK S
Citation: Jd. Adachi et al., INTERMITTENT CYCLICAL THERAPY WITH ETIDRONATE PREVENTS BONE LOSS IN CORTICOSTEROID-TREATED PATIENTS AND REDUCES FRACTURE RATE IN A SUBGROUPOF POSTMENOPAUSAL WOMEN, Journal of bone and mineral research, 12, 1997, pp. 267-267
Authors:
STEMARIE LG
ADACHI JD
CAMERON EC
DAVISON SK
DIAS RP
JUAN D
LENTLE B
STEPHENSON GF
STURTRIDGE EC
TENENHOUSE A
WHITE JM
Citation: Lg. Stemarie et al., AN OPEN-LABEL, MULTICENTER TRIAL ON INTERMITTENT CYCLICAL THERAPY WITH ETIDRONATE IN POSTMENOPAUSAL OSTEOPOROTIC WOMEN, Journal of bone and mineral research, 12, 1997, pp. 485-485
Authors:
CRILLY R
SEBALDT RJ
ADACHI JD
BROWN JP
HANLEY DA
OLSZYNSKI WP
PETRIE A
STEMARIE LG
HODSMAN AB
Citation: R. Crilly et al., COMPARISON OF BMD MEASUREMENTS AT 6 AND 12 MONTHS IN ASSESSING RESPONSE TO ETIDRONATE IN OSTEOPOROSIS, Journal of bone and mineral research, 12, 1997, pp. 486-486
Authors:
PAPAIOANNOU A
ADACHI JD
PARKINSON W
GAGNON M
BEDARD M
OCONNOR A
TUGWELL P
JOLLY E
CRANNEY A
Citation: A. Papaioannou et al., EFFECTS OF EDUCATION ON DECISIONS TO START HORMONE-THERAPY BY POSTMENOPAUSAL WOMEN AT RISK FOR FRACTURES, Journal of bone and mineral research, 12, 1997, pp. 505-505
Authors:
PAPADIMITROPOULOS BA
PAPAIOANNOU A
WIKTOROWICZ M
GOEREE RA
ADACHI JD
COYTE PC
JOSSE RG
GREENWOOD CE
Citation: Ba. Papadimitropoulos et al., WHERE DO CANADIAN HIP FRACTURE PATIENTS GO ONE-YEAR POST DISCHARGE FROM ACUTE-CARE HOSPITALS, AND WHAT IS THE COST OF THEIR FOLLOW-UP CARE, Journal of bone and mineral research, 12, 1997, pp. 560-560
Authors:
MULLER ME
ADACHI JD
WEBBER CE
Citation: Me. Muller et al., BONE MASS AND STRUCTURE MEASUREMENTS BY DXA, PQCT AND ULTRASOUND AT THE HIP, SPINE, RADIUS AND HEEL IN WOMEN WHO ARE OSTEOPOROTIC OR OSTEOPENIC, Journal of bone and mineral research, 12, 1997, pp. 569-569
Authors:
WIKTOROWICZ M
PAPAIOANNOU A
ADACHI JD
PAPIDIMITROPOULOS EA
BRAZIL K
Citation: M. Wiktorowicz et al., HOW COMMONLY DO PHYSICIANS ATTRIBUTE - HIP-FRACTURES TO OSTEOPOROSIS IN ACUTE-CARE, Journal of bone and mineral research, 12, 1997, pp. 601-601
Authors:
HANLEY D
SACCOGIBSON NA
ADACHI JD
HODSMAN AB
BROWN JP
PACK S
CHINES AA
Citation: D. Hanley et al., ETIDRONATE THERAPY IN PATIENTS ON HIGH-DOSE CORTICOSTEROIDS - DIFFERENCES IN BONE-RESORPTION MARKER RESPONSES, Journal of bone and mineral research, 12, 1997, pp. 626-626
Authors:
SEBALDT RJ
ADACHI JD
GORDON M
STEELE M
PETRIE A
GOLDSMITH C
Citation: Rj. Sebaldt et al., INTERMITTENT CYCLIC THERAPY WITH ETIDRONATE PREVENTS CORTICOSTEROID-INDUCED BONE LOSS - 3 YEARS OF FOLLOW-UP, Journal of bone and mineral research, 12, 1997, pp. 630-630
Authors:
SACCOGIBSON NA
PACK S
CHINES AA
ADACHI JD
Citation: Na. Saccogibson et al., BONE TURNOVER MARKERS PREDICT CHANGES IN BONE-MINERAL DENSITY IN PATIENTS TREATED WITH CORTICOSTEROIDS, Journal of bone and mineral research, 12, 1997, pp. 635-635